Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase

Giuseppe Barbaro, Gabriella Di Lorenzo, Maurizio Soldini, Giuseppe Giancaspro, Benvenuto Grisorio, Adriano M. Pellicelli, Giulia D'Amati, Giorgio Barbarini

Research output: Contribution to journalArticle

Abstract

Objective: To define whether the development of encephalopathy influences the clinical course of HIV-associated cardiomyopathy (HIV-DCM) in relation to the myocardial expression of tumour necrosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS). Design: Prospective study. Setting: University hospitals and AIDS centres. Methods: 115 HIV-infected patients with echocardiographic diagnosis of HIV-associated cardiomyopathy (34 with encephalopathy and 81 without encephalopathy) were followed for a mean of 24 ± 3.2 months. All patients underwent endomyocardial biopsy for determination of myocardial immunostaining intensity of TNF-α and iNOS. Cerebrospinal fluid (CSF) from patients with encephalopathy was examined for the presence of viruses. Patients underwent clinical examination every 3 months and echocardiographic examination every 6 months. The intensity of TNF-α and iNOS immunostaining was also evaluated on postmortem cerebral tissue of patients who died of congestive heart failure (CHF). Results: A greater impairment of echocardiographic parameters was observed in patients with HIV-associated cardiomyopathy after development of encephalopathy. These parameters tended to worsen progressively during the follow-up period and were inversely correlated with HIV-1 viral load, CD4 cell count, mini mental status score and the intensity of myocardial and cerebral TNF-α and iNOS staining. CSF specimens were available in 29 patients with encephalopathy. HIV-1 sequences were detected in CSF of all these patients with cytomegalovirus sequences in two. The mortality rate for CHF was greater among patients with encephalopathy (73% versus 12%). Conclusions: The development of encephalopathy has an adverse effect on the clinical course of HIV-associated cardiomyopathy. In the relationship between cardiomyopathy and encephalopathy, the activation of iNOS by TNF-α may have a signifi cant pathogenetic role in HIV disease. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish
Pages (from-to)827-838
Number of pages12
JournalAIDS (London, England)
Volume14
Issue number7
DOIs
Publication statusPublished - 2000

Keywords

  • Dilated cardiomyopathy
  • Encephalopathy
  • Factor-alpha
  • HIV
  • Inducible nitric oxide synthase
  • Tumour necrosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase'. Together they form a unique fingerprint.

  • Cite this